Efficacy and safety of lactulose for the treatment of irritable bowel syndrome
Conclusions:
This study will provide the evidence for the clinical efficacy and safety of lactulose for the treatment of IBS.
PROSPERO registration number:
PROSPERO CRD42019140639.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research